Autolus is a biopharmaceutical company. It is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014. Since its inception, the company has undergone rapid growth, systematically adding the capabilities needed to manufacture and develop its programmed T cell product candidates. Autolus is committed to bringing life-changing treatments to cancer patient...
Autolus is a biopharmaceutical company. It is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014. Since its inception, the company has undergone rapid growth, systematically adding the capabilities needed to manufacture and develop its programmed T cell product candidates. Autolus is committed to bringing life-changing treatments to cancer patients by reprogramming their own T-cells to combat the treatment of haematological malignancies and solid tumours.
Upgrade this company profile// Update & customize all content. Ask PharmaCompass, click HERE.
Country
UNITED KINGDOM
Address
Forest House, 58 Wood Lane White City, London, W12 7RZ
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
